Dr. Konduri’s broad research goals are to improve outcomes for newborn infants who are critically ill with respiratory failure. He plans to accomplish this by a combination of basic, translational and clinical research. He has had the privilege of being involved in the development of cutting edge vasodilator therapy for neonatal pulmonary hypertension, which has greatly improved the survival rates for neonates with this illness. Dr. Konduri plans to continue this research to improve long term outcomes for affected infants. He offers all these cutting edge therapies and has outstanding outcomes for neonates at our NICU at Children’s Wisconsin.